VITAMIN B12 ADMINISTRATION FACILITATES THE ANTI- PSYCHOTIC AND PAIN-RELIEVING EFFECTS OF QUETIAPINE, IN THE ALZHEIMER PATIENTS WITH PSYCHOTIC SYMPTOMS | [Journal of Ayub Medical College • 2021]

Author(s):

1. Alireza Vakilian: Geriatric Care Research Center, Rafsanjan University of Medical Sciences, Rafsanjan-Iran. Department Neurology, Faculty of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran

2. Amir Moghadam Ahmadi: Department Neurology, Faculty of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan-Iran;Non- Communicable Diseases Research Center. Rafsanjan University of Medical Sciences, Rafsanjan-Iran.

3. Moslem Heidari: Department Neurology, Faculty of Medicine, Rafsanjan University of Medical Sciences,Rafsanjan-,Iran

4. Nazanin Jalali: Department Neurology, Faculty of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan-Iran;C linical Research Development Center, Ali Ibn Abitalib Hospital, Rafsanjan University of Medical Sciences-Iran,

5. Mohammad Nazer: Psychiatry Department, Faculty of Medicine, Rafsanjan University of Medical Sciences,Rafsanjan-,Iran

6. Mohammad Zare Bidaki: Immunology of InfectiousDiseases Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences,Rafsanjan,iran.; Department of Microbiology, Faculty of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan-Iran

7. Seyed Meysam Hashemi: Clinical Research Development Center, Ali Ibn Abitalib Hospital, Rafsanjan University of Medical Sciences-,,Iran

8. Mohammad Mirabzadeh: Clinical Research Development Center, Ali Ibn Abitalib Hospital, Rafsanjan University of Medical Sciences-,,Iran

9. Amirreza Rezaei: Clinical Research Development Center, Ali Ibn Abitalib Hospital, Rafsanjan University of Medical Sciences-,,Iran

10. Morteza Amirteimoury: Clinical Research Development Center, Ali Ibn Abitalib Hospital, Rafsanjan University of Medical Sciences-,,Iran

11. Pooria Najmaddini: Clinical Research Development Center, Ali Ibn Abitalib Hospital, Rafsanjan University of Medical Sciences-,,Iran

Abstract:

Background: Psychotic symptoms in Alzheimer's disease (AD) patients are a problem in medicine. The efficacy of the vitamin B12 on the treatment of the psychotic symptoms of the AD patients in the association with antipsychotic drugs Quetiapine and Risperidone, was evaluated in this Study. Methods: The effects of vitamin B12 along with two other drugs were studied on the Mini-Mental State Examination (MMSE), Clinical Global Impression (CGI), Brief Psychiatric Rating Scale (BPRS) and pain Visual Analogue Scale (VAS) in 47 AD patients with psychotic symptoms, including 4 groups, psychotic AD patients treated with Risperidone, Risperidone plus vitamin B12, Quetiapine and Quetiapine plus vitamin B12. Results: The results showed that Quetiapine improved all of the psychotic criteria, while Quetiapine plus vitamin B12 had better results on BPRS after 2 weeks, VAS score and MMSE. Risperidone also improves all of the criteria except MMSE and drug efficacy index, while, vitamin B12 neutralize the effects of the Risperidone on the BPRS, VAS, and severity of illness. Conclusions: Due to these results, Quetiapine is the preferred antipsychotics drug and Vitamin B12 plays an effective role in treatment as an adjunct therapy.

Page(s): 744-751

DOI: DOI not available

Published: Journal: Journal of Ayub Medical College, Volume: 33, Issue: S1, Year: 2021

Keywords:

Psychosis , Quetiapine , Alzheimer disease , Vitamin B12

References:

References are not available for this document.

Citations

Citations are not available for this document.

Citations

Downloads

Views